자동 로그아웃 안내

로그아웃 아이콘

로그아웃 시간이 남았습니다.
로그인 시간을 연장하시겠습니까?

로그아웃을 연장하시려면 아래 연장하기 버튼을 눌러주세요.

본문 바로가기

연구소

연구논문

  • Home
  • 연구소
  • 연구논문

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Utility of the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure primary health outcomes in cancer patients: a systematic review 조현순
(암관리학과)
조현순:Tran Mai (암관리학과 박사과정학생) , 박정은 (NECA):이준기(서울대), 장윤정, 정유석. Utility of the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure primary health outcomes in cancer patients: a systematic review SUPPORTIVE CARE IN CANCER. 2020-10-15; 2020; Online:Published. IF 2.635 (2019)
Tran Thi Xuan Mai
(암관리학과)
IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer 김보람, 이창훈
김보람, 이창훈:노승배:이승훈, 변현정. IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020-10-15; 2020; 21(20):7622~. IF 4.556 (2019)
노승배
(이행성연구부)
Association between early treatment hospitals, serum cholesterol level and cardiovascular disease risk in dyslipidemia patients Seung Ju Kim
Seung Ju Kim:한규태:. Association between early treatment hospitals, serum cholesterol level and cardiovascular disease risk in dyslipidemia patients EUROPEAN JOURNAL OF PUBLIC HEALTH. 2020-10-10; 2020; Online:Published. IF 2.391 (2019)
한규태
(암관리정책부)
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial 박중원
(임상의학연구부)
박중원:김태현,고영환:김보현,김민주,이주희,박보람. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial JOURNAL OF HEPATOLOGY. 2020-10-05; 2020; S0168-8278(20):33670-9~. IF 20.582 (2019)
김태현
(융합기술연구부)
고영환
(영상의학과)
The Different Clinicopathological Features of Remnant Gastric Cancer Depending on Initial Disease of Partial Gastrectomy 국명철
(이행성연구부)
류근원
(임상의학연구부)
국명철, 류근원:한원호:엄방울, 윤홍만, 김영우. The Different Clinicopathological Features of Remnant Gastric Cancer Depending on Initial Disease of Partial Gastrectomy CANCERS. 2020-10-02; 2020; 12(10):E2847~. IF 6.126 (2019)
한원호
(중환자실)
Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A
Multi-Institutional Retrospective Study 서호경
(종양면역학연구부)
서호경:Hyung Suk Kim:김성한. Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study FRONTIERS IN ONCOLOGY. 2020-10-02; 2020; 10:568809~. IF 4.848 (2019)
Hyung Suk Kim
Novel robot-assisted thyroidectomy by a transaxillary gasinsufflation approach (TAGA): a preliminary report 정유석
(이비인후과)
류준선
(이비인후과)
정유석, 류준선:석준걸, 유창환:. Novel robot-assisted thyroidectomy by a transaxillary gasinsufflation approach (TAGA): a preliminary report GLAND SURGERY. 2020-10-01; 2020; 9(5):1267~1277. IF 2.19 (2019)
석준걸
(이비인후과)
유창환
(이비인후과)
Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer 국명철
(이행성연구부)
국명철:엄방울,류근원:윤홍만. Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer CHINESE JOURNAL OF CANCER RESEARCH. 2020-10-01; 2020; 32(5):614~620. IF 4.135 (2019)
류근원
(임상의학연구부)
엄방울
(암역학예방연구부)
Distinct metabolic preference of atypical KRAS mutant 정희선
(암생물학연구부)
정희선:정희선:. Distinct metabolic preference of atypical KRAS mutant ANNALS OF TRANSLATIONAL MEDICINE. 2020-10-01; 2020; 8(20):1326~. IF 3.297 (2019)
정희선
(암생물학연구부)
A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol Park Young Joo
Park Young Joo:Eun Kyung Lee: You Jin Lee, Jae Hoon Moon, Ka Hee Yi, Koon Soon Kim, Joo Hee Lee, Sun Wook Cho, Jungnam Joo, Yul Hwangbo, Sujeong Go, Do Joon Park. A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol ENDOCRINOLOGY AND METABOLISM. 2020-09-30; 2020; 35(3):571~577. IF 3.257 (2019)
이은경2
(이행성연구부)